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Background: Although, Plasmodium vivax is a rare parasite in most parts of Africa, it has significant public health
importance in Ethiopia. In some parts of the country, it is responsible for majority of malaria associated morbidity.
Recently severe life threatening malaria syndromes, frequently associated to P. falciparum, has been reported from
P. vivax mono-infections. This prompted designing of the current study to assess prevalence of severe malaria
complications related to P. vivax malaria in Ethiopia.
Methods: The study was conducted in two study sites, namely Kersa and Halaba Kulito districts, located in southwest
and southern parts of Ethiopia, respectively. Children, aged ≤ 10 years, who visited the two health centers during the
study period, were recruited to the study. Clinical and demographic characteristics such as age, sex, temperature,
diarrhea, persistent vomiting, confusion, respiratory distress, hepatomegaly, splenomegaly, hemoglobinuria, and epitaxis
were assessed for a total of 139 children diagnosed to have P. vivax mono-infection. Parasitological data were collected
following standard procedures. Hemoglobin and glucose level were measured using portable hemocue instrument.
Results: Median age of children was 4.25 ± 2.95 years. Geometric mean parasite count and mean hemoglobin level
were 4254.89 parasite/μl and 11.55 g/dl, respectively. Higher prevalence rate of malaria and severe malaria
complications were observed among children enrolled in Halaba district (P < 0.001). However, severe parasitemia was
higher (72.4%) among children who visited Serbo health center (Kersa district). Male children had significantly higher
risk of malaria infection (OR = 1.9, 95% CI, 1.08 to 3.34), while female had higher risk to anemia (OR = 1.91, 95% CI,
1.08 - 3.34). The observed number of anemic children was 43%, of which most of them were found in age range from
0–3 years. Furthermore, P. vivax malaria was a risk factor for incidence of anemia (P < 0.05) in the two sites.
Conclusion: P. vivax associated severe malaria complications observed in this study was lower than those reported
from other countries. However, incidence of severe malaria complications in one of the sites, Halaba district, where
there is highest treatment failure to first line drug, could have significant impact on national malaria prevention and
control activities.
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Plasmodium vivax is the second important parasite of
human malaria widely perceived as causing mild and
self-limited illness. Unlike P. falciparum, it has wider
geographical distribution. Though the public health
importance of this parasite is overshadowed by P.
falciparum, it is important parasite outside Africa, mainly* Correspondence: tsigeketema@gmail.com
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distribution, and reproduction in any mediumin Asia and South America. It causes more than 390
million clinical cases per year [1]. P. vivax, previously
thought benign parasite, is recently reported to cause life
threatening complications among children from endemic
regions such as Indonesia, India and Brazil [2-4]. Some
of the reported severe malaria complications are cerebral
malaria, dysfunction of different organs, hypoglycemia,
jaundice, thrombocytopenia, renal impairment, hepatic
dysfunction, acute kidney injury and hypotension [5-9].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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young children in most vivax-endemic areas [2,10]. Though
the mechanism of malaria associated severe anemia
incidence is multi-factorial, there are established facts
on intensive hemolysis of circulating infected RBCs, non
infected erythrocytes due to glycosylphosphatidyl-inositol
toxin released, and dyserythropoiesis that occur to the
effect of different cytokines and other inducer of inflam-
mation such as hemozoin [11-13].
Unlike other countries in Africa, prevalence of P. vivax
infection in east Africa, particularly in Ethiopia is higher.
In some areas of the country, the prevalence rate exceeds
even 70% of total malaria infections. This was previously
accounted to high Duffy blood group positivity of most
population of the country [14], but recently contradictory
reports are coming [15,16].
Although P. vivax malaria is highly prevalent in some
parts of Ethiopia and its risk to drug resistance is increasing
[17-20], to the authors’ knowledge study conducted on
P. vivax associated severe malaria complication is almost
none. Thus, it is rational to assess the current status of
P. vivax related severe malaria complications in order to
estimate the associated burden among biologically risked
groups, children, in the endemic areas.Methods
Description of the study area
The study was conducted in two of malaria endemic areas
of Ethiopia, namely Kersa and Halaba districts, particularly
at Serbo and Halaba Kulito health centers, respectively.
The two sites were selected in order to compare incidence
of severe P. vivax malaria complications in areas where
there is intense P. vivax transmission (Halaba) and
lesser transmission (Kersa). Geographically, Kersa district
is located between altitudes ranging from 1,740- 2,660
meter above sea level (masl), which is relatively high
land, where as Halaba district is found within altitudes
of 1554–2149 masl (Figure 1).
The climatic zones of the districts have mainly
consisted of mid-land and low-land. In Halaba, the most
important parasite is P. vivax and it was responsible for
more than 70% of the total malaria infection; whereas, P.
falciparum is an important parasite in Kersa district and
accounts for about 60% of all malaria infections in the
area [19,20]. The mean annual rain fall is 1150 mm in
Kersa and it ranges between 601–1200mm in Halaba. In
addition, the average annual temperature ranges from
17.6- 22.5°C and 11.2 -29.6°C at Halaba and Kersa,
respectively. In both areas, malaria is the most important
health problem and the period from September to
December is known as malaria peak season. The principal
vector that transmits the disease in the country is Anopheles
arabiensis.Study population
Study participants were children who visited the two health
centers during the study period, September- December,
2009 and 2011, and had symptoms of malaria infection.
The inclusion criteria used were: children aged ≤ 10 years,
being infected with P. vivax mono-infection, without any
chronic illness or not admitted to Tb and ART clinic,
without prior medication, having clinical symptoms like
fever, chills, malaise, headache, vomiting, history of fever
for about 48 hours before admission, and volunteer to
participate in the study.
Data collection
Clinical and demographic data of the study participants
(children) were recorded on pre-designed case record
form by trained health professionals working at the two
health centers. Accordingly, body temperature of each
child was measured using digital thermometer; clinical
symptoms such as fever, headache, hyperpyrexia, epistaxis,
persistent vomiting, impaired consciousness, respiratory
distress, hemoglobinuria, splenomegaly, and hepatomegaly
were assessed. Children with at least one or more
symptoms of severe malaria complications set by WHO
[21] were classified as severe P. vivax cases.
Data from laboratory tests were collected by experienced
laboratory technicians working in the health centers.
Accordingly, a drop of blood sample was collected on
clean glass slide from lancet pricked finger to prepare
thin and thick blood smears in duplicate per patient for
microscopic examination. Thick and thin blood smears
were stained with 10% Giemsa (pH = 7.2, for 10 minutes),
while thin smears were fixed in methanol prior to Giemsa
staining. Malaria parasite was identified by observation
of the smears and the morphological appearance of the
parasite in the infected RBC under oil immersion objective.
Parasite load was calculated after counting asexual parasites
per 200 white blood cells (WBC), assuming mean WBC
count is 8,000/μl. Each blood smear was examined by
experienced laboratory technician in the health centers
and then re-checked by certified laboratory technician at
Jimma University. The degree of parasitaemia was graded
as mild, moderate, and severe, when a count was between
1–999 parasite/μl, 1000-9999/μl, >10000/μl, respectively,
following method described by Cheesbrough [22].
From the same pricked finger, few drops of blood
samples were taken for measurement of hemoglobin
(Hb) and blood glucose concentration (Glu) using hand-
held portable hemoglobin and glucose analyzer Hemocue™
(haemoglobinometer, Angelholm, Sweden). Hypoglycemia
was considered when blood glucose concentration
was < 40 mg/dl. Children with Hb level < 11 g/dl were
considered anemic. Briefly, level of anemia was classi-
fied as severe, moderate and mild, when Hb concentra-
tion < 5 g/dl, between 5 and 8 g/dl, and between 8 and
Figure 1 Map of the study sites.
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fication for severe P. falciparum malaria [21]. Hyperpy-
rexia was considered when body temp was > 40°C. All
children were treated with chloroquine (25 mg base/kg) as
per the recommendation of National Malaria Treatment
Guideline [23].
Data analysis
Data was analyzed using SPSS statistical software
(version 16.0). Descriptive statistical tests were usedFigure 2 Number of malaria cases observed at Halaba district, SNNPRfor analysis of some clinical, demographic and para-
sitological data. Associations between variables were
evaluated using Pearson correlation test and presented
using matrix plot. Odd ratio was employed to describe
strength of associations between variables in groups.
Independent variables were compared using Mann–
Whitney U test. Median was considered over mean
for non-normally distributed variables. In all analysis,
significance level was considered at 95% confidence
interval., Ethiopia.
Table 1 Clinical and demographic characteristics of
children infected with P. vivax at Halaba and Kersa
districts, Ethiopia
S.No Characteristics Frequency (n = 139)
1 Age (median) 4.25 ± 2.95 years
2 Sex
• Male 58% (n = 80)
• Female 42% (n = 59)
3 Fever at time of enrollment 55.4% (n = 77)
4 History of fever for about 48 hours 94.2% (n = 131)
5 Mean body Temp (range) 37.43 (36.5-40.7°C)
6 Vomiting 39% (n = 54)
7 Diarrhea 21% (n = 29)
8 Average days of illness (range) 2.92 (2-7 days)
9 Anemic cases (Hb < 11 g/dl) 43% (n = 60)
10 Median Hb level (range) 11.55 (4.7-15.2 g/dl)
11 Median Glucose concentration (range) 103 (36–170 mg/dl)
12 Geometric mean parasite (range) 4254.89 ±8104.3
(320–36,590 parasite/μl)
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The study was ethically approved by Ethical Review Com-
mittee of College of Natural Sciences, Jimma University.
Written consent/assent was obtained from guardians of
the study participants prior to data collection.
Results
Malaria prevalence
During the study period, a total of 1497 blood samples
were collected from presumptive malaria cases aged ≤ 10
years. About 31.9% (478/1497) were positive for malaria
infection. Among these, 32.64% (156/478) and 67.36%Figure 3 Association between age, hemoglobin level and parasite co
districts, Ethiopia.(322/478) were infected with P. vivax and P. falciparum,
respectively. Based on the inclusion criteria, a total of 139
children with P.vivax who fulfilled the inclusion criteria
(n = 58 from Kersa and n = 81 from Halaba) were retro-
spectively analyzed. The rest (17/156) were excluded
from the study due to prior medication, lack of consent
from their guardians, and few due to admission to Tb
clinic. The prevalence of P. vivax malaria was significantly
different (P < 0.05) at Halaba district and significantly
higher among children aged ≤ 5 years (P < 0.01). Sample
composition in terms of sex and age did not differ signifi-
cantly (p > 0.05) between the two study sites. Even if the
overall malaria prevalence shows a declining trend across
the country, the number of malaria patients is still high in
Halaba district (Figure 2).
Clinical and demographic characteristics
Based on the observed clinical and demographic charac-
teristics, median age of the children was 4.25 ± 2.95 years.
Male children had significantly higher risk of malaria
infection (OR = 1.9, 95% CI, 1.08 to 3.34). At the time of
admission, about 39% (54/139) and 21% (29/139) of the
children had vomiting and diarrhea, respectively. Though
most children, 94.2% (131/139) had a history of fever for
the past 48 hours, only 55.4% (77/139) of them were
febrile and had axillary temperature ≥ 37.5°C during
enrollment. The median Hb and Glu concentration were
11.55 (4.7-15.2 g/dl) and 103 (36–170 mg/dl), respectively,
while the geometric mean parasite count (asexual stage)
and average body temperature were 4254.89 (320–36,590
parasite/μl) and 37.43 (36.5-40.7°C), respectively (Table 1).
Pearson correlation analysis revealed that age of children
was negatively correlated to parasite count (r = −0.2358,
p < 0.05) but had positive correlation to hemoglobin levels.
Accordingly, as age of children increased the parasiteunts among children infected with P. vivax at Halaba and Kersa
Table 2 Prevalence of severe malaria complications
among P. vivax infected children at Halaba and Kersa
districts, Ethiopia
S. No Characters Sites
Halaba Kersa
1 Malaria prevalence n = 81 (58.27%) n = 58 (41.72%)
2 Anemic children (Hb < 11 g/dl) n = 37 (45.68%) n = 23 (39.65%)
3 Severe anemia (Hb < 5 g/dl) 6 2




6 Respiratory distress 2 1
7 Hyperpyrexia 1 3
8 Persistent vomiting 1 1
9 Vomiting 21/81(25.9%) 27/58 (46.55%)
10 Diarrhea 23/81 (28.39%) 14/58 (24.1%)
11 Febrile 48/81 (59.26%) 29/58 (50%)
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P < 0.001). However, there was no significant differences
(r = 0.057, p > 0.05) between Hb level and parasite count
(Figure 3).
Severe malaria
Among 139 children, a total of 19 (13.67%) fulfilled at
least one of the WHO criteria for severe malaria [21].
Some of these syndromes were; persistent vomiting
(10.5%, n = 2), respiratory distress (15.8%, n= 3), hypo-
glycemia (10.5%, n=2), hyperpyrexia or temperature >40°C
(21%, n = 4), and severe anemia (42%, n = 8). But, none
had symptoms like hepatomegaly, splenomegaly, epistaxis,
confusion or coma, and hemoglobinuria or discoloration
of urine. Severe malaria syndromes were significantly
higher (OR = 3.16, 95% CI, 1.77- 5.6) among children
who visited Halaba Kulito health center (Table 2). Chil-
dren with severe parasitemia, parasite count >10,000 para-
site/μl, were significantly higher (P < 0.001) in Kersa
(Serbo health center). Likewise, vomiting cases were
significantly higher (OR = 2.52, 95% CI = 1.39 - 4.57)
among children enrolled at Serbo health centre. However,
incidence of diarrhea and fever were not significantly
different (P > 0.05) between the two sites. Number ofTable 3 Incidence of severe anemia, parasitemia and hypogly
and Kersa districts, Ethiopia
No Age (year) Hb level (g/dl)
< 5 5 < Hb < 8 8 < Hb < 11 1
1 0-3 7 11 15
2 >3-6 1 5 10
3 >6-10 0 0 11
Total 8 16 36children with more than one severe malaria symptoms
were very few (n = 6) and most of them had severe anemia
with other syndromes including persistent vomiting (n = 1),
respiratory distress (n = 3), and hyperpyrexia (n = 2).
The frequency of incidence of anemia (43%, ± 9.7,
33.3-53%) was significantly higher (P < 0.05) among
children within the age range of 0 - 3 years than other
categories (Table 3). Severe anemia was observed in
eight children aged between 0–3 years (n = 7) and 4
years (n = 1). Most severe anemic cases (75%, n = 6/8)
were observed in Halaba district. In terms of sex, female
children had significantly higher risk of anemia (OR = 1.91,
95% CI, 1.08 - 3.34). Severe parasitemia was significantly
different (OR = 0.1854, 95%CI, 0.088 - 0.39) among
anemic children. The study showed that P. vivax malaria
was a risk factor for incidence of anemia (P < 0.05).
Severe parasitemia was observed in 41 children with
almost similar proportion in all age groups except for
children < 3 years (43.9%, n = 18/41) who was found to
have higher parasitemia. Hb level and parasite count of
children in the age category of 0–3 years was compared
with those in the highest age category (>6 years) using
Mann–Whitney U test. The result showed that Hb level
was significantly different (P < 0.01) between the two
age categories, but parasite count didn’t show significant
difference (P > 0.05). Parasite counts of all children with
severe anemia were found in the range of 1000–9999
parasite/μl.
Discussion
The prevalence rate of malaria observed in this study
was 31.9%, which was much lower than the very recent
report from Nigeria (81.9%) [24]. This might be due to the
intense and diverse malaria control strategies undertaken
in most parts of Ethiopia. The intervention made so far
has significantly reduced prevalence of malaria in some
endemic areas. As evidence, during the second phase of
this study (in 2011), the numbers of malaria patients
observed at Serbo health center were very few for recruit-
ment in the study. At Halaba district, however, though the
trend of malaria prevalence appears declining, the num-
bers of malaria patients visiting the health center were still
high. For instance, in the same year (2011), among a total
of 27,499 malaria suspected patients, 14,775 (53.73%) werecemia among children infected with P. vivax at Halaba
Parasite count/μl Glucose level (mg/dl)
-999 1000-9999 >10000 < 40 >40
7 28 18 2 35
11 22 13 0 33
15 15 10 0 30
33 65 41 2 137
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P. vivax and the rest were accounted to P. falciparum
(Unpublished data, Annual Report on Malaria Prevalence
by Halaba Kulito health center, 2011).
Most of the children enrolled in this study were found
in age group ≤ 5 years. In this age category higher load of
parasitemia and incidence of severe anemia, but lower con-
centration of hemoglobin was observed. This strengthens
the fact that children in this age group who live in holo or
hyperendemic areas are biologically risked group [25].
This is because of the development of poor immunity
against the disease [21], but as they get older and repeatedly
exposed to the disease they gradually develop protective
immunity to malaria [26].
Percentage of anemic cases documented in this study
(43%) was higher than the earlier 34% reported from
children [27] and 30.5% from among adults [28] in
South–Western India. Usually anemia is associated with
intense hemolysis of RBCs due to higher parasitemia
such as in the case of infection with P. falciparium.
However, due to selective preference to only young RBCs
by P.vivax, it appears that the number of hemolyzed RBC
during P.vivax is minimal. Thus, the incidence of anemia
might occur as a result of rigor inflammatory reactions
due to pro-inflammatory response and cytokines activation
[29] and less deformability of RBCs during P. vivax infec-
tion [30,31]. On the other hand, the rate of non infected
RBCs hemolysis for every infected RBC destroyed could
contribute to the incidence of anemia as number of non-
parasitized RBCs removed from circulation during P. vivax
is much higher (~32) than P.falciparum (~8) [32,33].
Frequency of P.vivax associated severe malaria compli-
cations documented in this study (13.67%) was less than
those report from Eastern Sudan (18%) from among
children admitted to hospital due to severe P. vivax mal-
aria [8], but slightly higher than those from Venezuela
(10.26%) [34]. In agreement with report from Eastern
Sudan [8], the most prevalent severe malaria complication
observed in this study was severe anemia (36.36%)
followed by hyperpyrexia, respiratory distress and persistent
vomiting. Incidence of hypoglycemia was minimal. Other
severe malaria symptoms including hepatomegaly, spleno-
megaly, confusion, epistaxis and persistent vomiting were
not observed, except the respiratory distress cases which
was in agreement with the recent report from India [35].
With regard to sites, the numbers of children with
severe malaria complications were higher among those
children who visited Halaba Kulito health center, the site
where the highest (13%) treatment failure to chloroquine
(the first line drug) by P.vivax malaria was documented
[20]. Siliva-Filho et al. [36] elaborated that when there is
drug resistance trait in a certain area, it increases peripheral
parasitemia for a longer time and enhance hemolysis of
RBCs. As a consequence, persistent of the parasite inhosts blood can increase incidence of severe malaria
syndromes. This is evidenced by frequent occurrence of
severe anemia in such localities [37]. On the other hand,
intense disease transmission in Halaba district might have
contributed to the higher severe malaria cases. It is also
affirmed that in an area where there is intense malaria
transmission there is high incidence of severe malaria
morbidity which results in higher hospital admission
among young children [38].
Conclusion
As P.vivax malaria parasite had already developed resistant
to the first line drug, chloroquine, in one of these study
sites, underestimation of complications caused by P. vivax
malaria could have significant impact on current malaria
control and prevention activities being under taken in the
districts. Thus, it calls for special attention and frequent
surveillance by concerned bodies in order to achieve the
sought national malaria reduction plan.
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